Oxford to Pioneer Precision Cancer Medicine as a New Cancer Research UK Major Centre
The Cancer Research UK Oxford Centre has been awarded Major Centre status by Cancer Research UK. The award was made in recognition of the world-leading science taking place in Oxford, the innovative collaborations by Centre members, and the power of the cancer research network that has already been established. As a result of the award, the Centre will receive an extra £5 million in funding over the next 2 years.
The Cancer Research UK Oxford Centre was formed in 2000 with the vision to harness the breadth and depth of research activity across the University and NHS Trust. With its new status, the Centre will continue to act as a vital research hub for the Cancer Research UK centre network, drawing together expertise, encouraging collaborative research, and bridging the gap between innovative laboratory work and benefits for patients.
Priorities of the Centre include the development of new immunotherapies and bringing together biologists, physicists, mathematicians and engineers to deliver new treatments. Investment will tie together advances in diagnostics, genomics, surgery, imaging, radiotherapy, and drug development to fulfil the Centre’s vision for precision medicine.
Professor Gillies McKenna, Head of the Department of Oncology and Director of the Cancer Research UK Oxford Centre, said: “We look forward to making the most of our role as a Major Centre and leader in cancer research in the UK. The new initiative will bring researchers and clinicians together in sustainable networks with longer term investment. This will allow us to combine the latest developments in radiotherapy and surgery with clinical trials of new drugs, providing the best evidence to guide cancer treatment and enhance cancer cure rates.”
The Cancer Research UK Manchester Centre, and Cancer Research UK Cambridge Centre have also achieved Major Centre status.
Read the full story on the Cancer Research UK Oxford Centre website.